Profusa, Inc.

Profusa, Inc. (Nasdaq: NVAC) filed a Form 10-Q with the Securities and Exchange Commission on November 15, 2024, marking a routine quarterly reporting milestone for the company following its entry into the public markets via a SPAC transaction. Profusa operates in the healthcare and medical device sector, developing implantable biosensor platforms designed to enable continuous, real-time monitoring of physiological biomarkers within the body, with applications spanning clinical diagnostics and consumer health. The November 2024 filing provides an updated financial snapshot of the company as it advances its commercial biosensor programs. Investors and analysts tracking NVAC can sign up at SpacDesk for full deal history, financial data, and filing intelligence across the SPAC universe.